Literature DB >> 2115881

Lacto- and ganglio-series glycolipids are adhesion receptors for Neisseria gonorrhoeae.

C D Deal1, H C Krivan.   

Abstract

The role of glycolipids as adhesion receptors for Neisseria gonorrhoeae is examined. Serum-resistant isolates, piliated and nonpiliated isogenic variants, as well as gonococci deficient in lipooligosaccharide and protein II, bind specifically to terminal and internal GlcNAc beta 1-3Gal beta 1-4Glc and GalNAc beta 1-4Gal beta 1-4Gcl sequences in lacto- and ganglio-series glycolipids, respectively, as measured by overlaying glycolipid chromatograms with 125I-labeled organisms. The binding activity was not affected by changing the growth conditions of the organism, as the gonococci bound to both classes of glycolipids when grown anaerobically, microaerophilically on agar or in broth, or under iron-limited conditions. The gonococci do not bind to lacto-sylceramide (Gal beta 1-4Glc beta 1-1Cer) derived from lacto-N-triaosylceramide or from asialo-GM2 by treatment with N-acetyl-beta-hexosaminidase, or to other neutral glycolipids tested. Although N. gonorrhoeae bound weakly to some gangliosides on thin-layer chromatograms, including sialylparagloboside and GM1, in solid phase assays the gonococci bound with high avidity to the sequence GalNAc beta 1-4Gal beta 1-4Glc, with moderate avidity to the sequence GlcNAc beta 1-3Gal beta 1-4Glc, and not at all to gangliosides. Interestingly, the 4.8-kDa component of gonococcal lipooligosaccharide, which contains lacto-N-neotetraose (Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc), strongly inhibits gonococcal-specific agglutination of human erythrocytes and inhibits the binding of labeled organisms to human paragloboside and lacto-N-triaosylceramide on thin-layer chromatograms. Possibly, this binding specificity explains why gonococci autoagglutinate in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115881

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Adherence to lipids and intestinal mucin by a recently recognized human pathogen, Campylobacter upsaliensis.

Authors:  F A Sylvester; D Philpott; B Gold; A Lastovica; J F Forstner
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  In the NadR regulon, adhesins and diverse meningococcal functions are regulated in response to signals in human saliva.

Authors:  Luca Fagnocchi; Eva Pigozzi; Vincenzo Scarlato; Isabel Delany
Journal:  J Bacteriol       Date:  2011-11-11       Impact factor: 3.490

3.  N-glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells.

Authors:  O Fumagalli; B D Tall; C Schipper; T A Oelschlaeger
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

4.  Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens.

Authors:  T M Wizemann; J Moskovitz; B J Pearce; D Cundell; C G Arvidson; M So; H Weissbach; N Brot; H R Masure
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Interactions between Campylobacter jejuni and lipids.

Authors:  C M Szymanski; G D Armstrong
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  Neisseria gonorrhoeae coordinately uses Pili and Opa to activate HEC-1-B cell microvilli, which causes engulfment of the gonococci.

Authors:  J M Griffiss; C J Lammel; J Wang; N P Dekker; G F Brooks
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Differences in the binding specificities of Pseudomonas aeruginosa M35 and Escherichia coli C600 for lipid-linked oligosaccharides with lactose-related core regions.

Authors:  I J Rosenstein; C T Yuen; M S Stoll; T Feizi
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

8.  Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors.

Authors:  F A Sylvester; U S Sajjan; J F Forstner
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 9.  Complex carbohydrates in drug development.

Authors:  R L Schnaar
Journal:  Adv Pharmacol       Date:  1992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.